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Four angiotensin-converting enzymes (ACE) containing silanediols 1 have been synthesized successfully in 8% overall 
yield in 8 steps from inexpensive starting materials such as diphenyldichlorosilane 5, β-methylallylic alcohol 7 and Ellman 
sulfinimine 9. 
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A part from similarity, there are a lot of differences 
between silicon and carbon. In general, the hydrated 
sp3 hybridization form of carbonyl group is 
energetically disfavored over their trigonal 
unhydrated sp2 counterparts. In contrast, silicon 
species strongly prefersp3 geometry to sp2 geometry1. 
Therefore, silandiol containing compounds have been 
synthesized for some decades to test for some 
biological activity purposes based on modification of 
enzymes2-4. For example, silanediol inhibitors of the 
serine protease coagulation cascade enzyme FXIa5, 
human neutrophil elastase6,7, serine protease8, anthrax 
lethal factor9, angiotensin-converting enzyme10 and 
the metalloprotease thermolysin11,12 and human 
immunodeficiency virus-1 protease13 were 
synthesized successfully. Moreover, silanediols have 
been investigated as acid-based catalysts. For 
instance, silanediols were active in catalyzing Diels-
Alder reactions14-16. From these examples, four 
angiotensin-converting enzymes (ACE) containing 
silanediols got most our attention since three of  
them inhibited interestingly angiotensin-converting 
enzymes at IC50 values (3.8-207 nM); the fourth 
diastereomer exhibited inhibition of angiotensin-
converting enzymes at 3200 nM that all paralleled 
with identical ketones. 
The first synthesis of these four silanediols was 
successfully synthesized in 2005 by Kim, J. et al.  
The ACE inhibitors (R,S,S)-1, (R,R,S)-1, (S,S,S)-1 and 
(S,R,S)-1+** were carried out following that rout 
required from 13 linear steps in % over all. 
In this synthesis, one stereo center was purchased 
and the other was formed without control10. In 2011, a 
short and asymmetric synthesis of (R,S,S)-1’s 
precursor was reported through an asymmetric 
synthesis of silyl ether gave an (S)-silafuran in 90% 
(94 ee%). It suffered from the high cost of ferrotane 
catalyst; the instability of asymmetric hydrosilylation 
and scale of reactions17. In this paper, a quick and 
inexpensive access for synthesis of these silanediols is 
reporting. 
In Figure 1, the silanediolprecursor 2 would be 
treated with strong acid to hydrolyze the two phenyl-
silicon bonds and the tert-butyl ester to form 
diflourosilane derivatives that would be easily converted 
to silanediols 1 11. The silane sulfinimide3 would be 
derived from Ellman sulfinimine and silyl lithium that is 
prepared when silane 4 reacts with lithium. The silane 4 
would be synthesized from inexpensive commercially 
available dichlorodiphenyl silane 5. 
 
Results and Discussion 
First of all, dichlorodiphenylsilane 5 was converted 
into diphenylsilane (6). This step was scaled up to 
120g (100mL) of dichlorodiphenylsilane (5). It is 
worth to know that the Fieser&Fieser helps to work 
—————— 
** Note: (S,S,S)-1, (R,S,S)-1, (S,R,S)-1, (R,R,S)-1 were denoted
for absolute cofiguration in order from left to right of the
structures. 




up with LiAlH4 (LAH) in safe. Product diphenylsilane 
(6) was distilled with Kugelrohr apparatus in 95% 
yield. Azobisisobutyronitrile (AIBN) initiated the 
radical substitution reaction between silane 6 and  
β-methylallylic alcohol 7 18 to obtain alcohol (±)-8, 
without further purification, the alcohol was protected 
with a methoxymethyl (MOM) group using the 
method of Gras et al. to give silane (±)-4 in 73% yield 
over three steps (Scheme I) 19. 
To take advantages of reaction of silyl lithium and 
sulfinimine20, the silane (±)-4 reacted with lithium 
metal in anhydrous tetrahydrofuran (THF) to form the 
silyllithium that was reacted with Ellman sulfinimine 
(R)-9 at –78°C to give sulfinamide 10 as a mixture of 
two diastereomers (R,R,R)-10 and (R,R,S)-10 in 45% 
yield (Scheme II). 
The Ellman auxiliary and MOM group of 10 
were removed with 4 M HCl in dioxane to yield a 
crude amine salt21 followed bySchotten-Baumann 
benzoylation gave the desired amide 11 in moderate 
yield. (2,2,6,6-Tetramethylpiperidin-1-yl)oxyl (Tempo) 
and bis(acetoxy)iodobenzene (BAIB)22,23 were the first 
used to oxidize the primary alcohol 11 to carboxylic 
acid 12 in moderate yield. The coupling reaction 
between acid 12 and L-proline usingdiethyl 
cyanophosphonate formed a mixture of amides 2 which 
were separated via a flash column chromatography. 
The retention factors of (R,R,S)-2 (Rf = 0.47)and 
(R,S,S)-2(Rf = 0.25)were different by 0.2, allowing for 
an easy separation with flash column chromatography 
(Scheme II) 10,17,24. The absolute configuration of 
(S,S,S)-2and (S,R,S)-2 were determined by comparing 
with the known-diastereomers11,17. 
Similar to synthesis of (S,S,S)-2 and (S,R,S)-2 in 
Scheme II, (S,R,S)-2 and (S,S,S)-2 were synthesized 
easily using Ellman sulfinimine (S)-9 (Scheme III). 
Since each diastereomer had a known 
stereogeniccenter on the proline moiety, X-Ray 
diffraction of (S,S,S)-2 was recorded (Figure 2). 
Therefore, the other was (S,R,S)-2 diastereomer. 
 
 
Scheme I — Synthesis of silane 4 
 
Dearylation of compounds 2 was accomplished 
with 60 equivalents of triflic acid (TfOH), followed 
by addition of NH4OH and HF to produce stable 
diflurosilanes14, as stable crystalline products, easily 
stored and easily hydrolyzed to the silanediols 1 





Reagents and solvents were purchased from Gelest, 
Aldrich, Fisher Scientific, Alfa Aesar, and Acros. 
Reaction solvents were purified using a ‘Grubbs-
style’ solvent dispensing system purchased from 
Glass Contour. Chromatography was conducted over 
silica gel (170e400 mesh, 60A ) or basic alumina 
(activated 50e200 micron). Analytical thin layer 
chromatography utilized Analtech Uniplate Silica Gel 
GF (250 micron) pre-coated glass plates. TLC 
visualization was conducted with UV light, iodine, 
and phosphomolybdic acid solution. 1H and 13C NMR 
spectra were recorded on Bruker Avance 400 
spectrometer and Bruker Avance III 500 spectrometers. 
Chemical shifts were measured relative to the residual 
solvent resonance. IR spectra were recorded on 
Mattson 4020 GALAXY Series FT-IR. Mass spectra 
were obtained with an Agilent 6520B. Accurate-Mass 
Q-TOF LC/MS and from the Mass Spectrometry 
Facility of University of California at Riverside. 
 
Preparation of diphenylsilane, 6 
To a mixture of lithium aluminium hydride (LAH, 
20.0 g, 0.521 mol) in anhydrous ether (500 mL)  was  
 
 
Figure 1 — Synthetic plan for silanediols 1 
 















Scheme IV — Synthesis of silanediols 1 






Figure 2 — X-ray diffraction of (S,S,S)-2 
 
cooled down at 5ºC, then dichlorodiphenylsilane  
(5, 100 mL, 0.474 mol) was added slowly within  
30 min. The resulting solution was refluxed for 1h. 
The reaction solution was iced at 0ºC followed by 
adding slowly water (20 mL), 15% aqueous sodium 
hydroxide (20 mL), water (60 mL). The mixture was 
gradually warmed to rt. and stirred for 15 min, added 
some anhydrous magnesium sulfate. The suspension 
was filtrated to obtain mother liquid through celite. 
Ether was removed in vacuo. Diphenylsilane (6) was 
distilled at 95-97°C at 13-15 mmHg as a clear liquid 
(83 mL, ∼95%). 
 
Preparation of (3-(methoxymethoxy)-2-methylpropyl) 
diphenylsilane, (±)-4 
Step 1: Preparation of 3-(diphenylsilyl)-2-methylpropan-1-
ol, (±)-8 
To a solution of diphenylsilane (6) (10.0 g, 54.3 
mmol) in heptane (150 mL) was added β-methyl 
allylic alcohol (5.5 mL, 65.2 mmol), tert-
dodecylmercaptan (1.2 mL, 5.4 mmol) and AIBN 
(0.44 g, 0.26 mmol). The resulting mixture was 
heated at 75°C for 19 h, and then concentrated  
in vacuo to give a mixture A. A small part of the 
mixture A was purified for analysis. Flash column 
chromatography using a gradient eluent (100:1 to 95:5 
hexane and ethyl acetate) gave alcohol 8 (85%) as a 
colorless oil. Rf = 0.6 (hexane / ethyl acetate 6:1); IR: 
3334(br), 3068, 301, 2929, 2873, 2117, 1535, 1427, 
1116, 700 cm-1; 1H NMR (400 MHz, CDCl3): δ 7.6-
7.3 (m, 10H), 5.0 (t, J = 4.5 Hz, 1H), 3.5 (ddd,  
J = 10.0, 6.1 Hz, 2H), 1.9-1.8 (m, 1H), 1.6 (br, 1H), 1.36 
(dt, J = 14.6, 4.6 Hz, 1H), 1.05 (dd, J = 10.0, 4.6 Hz, 
1H), 1.02 (d, J = 6.9 Hz, 3H); 13C NMR (100 MHz, 
CDCl3): δ 135.3, 135.2, 134.9, 134.7, 129.7, 128.2, 
70.3, 32.7, 19.3, 16.8; Exact mass: [M-Na]+calcd. for 
[C16H20NaOSi]+ 279.1176, found 279.1189. 
 
Step 2: Preparation of 3-(diphenylsilyl)-2-
methylpropan-1-ol ((±)-4) from 3-(diphenylsilyl)-2-
methylpropan-1-ol, (±)-8 
To a solution of alcohol (±)-8 (the rest of the mixture 
A in step 1) in dimethoxymethane (20 mL) was added 
TsOH.H2O (1.48 g, 6.8 mmol) and LiBr (0.66 g,  
6.8 mmol). The solution was stirred at rt for 30min, 
diluted with diethyl ether (100 mL). The aqueous layer 
was extracted with ether (3 x 30 mL). The combined 
organic layers were washed with 10% NaHCO3 (3 x 10 
mL) and brine (20 mL), dried over with sodium  
sulfate, concentrated in vacuo. Column chromatography 
gave pure (3-(methoxymethoxy)-2-methylpropyl) 






Lithium (90 mg, 13 mmol) was washed with THF 
(3 × 5 ml), added solution of compound (±)-4 (1.0 g, 
3.3 mmol) in THF (7 mL). The mixture was stirred at 
0 °C. Progress of reaction was monitored by 1H NMR. 
The silyllithium solution was transferred via syringe 
to (R)-9 (0.225 g, 1.1 mmol) in THF (5 mL) at -78ºC. 
The resulting solution was stirred at -78 °C for 3h and 
at rt for overnight. The solution was quenched  
by adding saturated NH4Cl solution (50 mL).  
The aqueous phase was extracted with EtOAc  
(3 x 20 mL). Combined organic layers were washed 
with water (3 x 10 mL), brine (2 x 10 mL), dried over 
with MgSO4, and then concentrated in vacuo. Flash 
chromatography with eluent gave 11 (0.2 g, 40%) as a 
mixture of two diastereomers. Rf = 0.43 (hexane / 
ethyl acetate 1:1); IR (neat): 3068, 2953, 2883, 1504, 
1454, 1427, 1149, 1068, 920, 702 cm-1; 1H NMR (400 
MHz, CDCl3): δ 7.57-7.20 (m, 15H), 4.44-4.43(d,  
J = 1.2 Hz (one diastereomer), d, J = 2.2 Hz, (another 
diastereomer), 2H), 3.84-3.77 (m, 1H), 3.256 and 
3.248 (s, 3H (two diastereomers)), 3.17-2.97 (m, 4H), 
1.72-1.65 (m, 1H), 1.26-1.16 (m, 1H), 1.00-0.99  
(s, 9H (two diastereomers)), 0.9-0.8 (m, 1H)  
0.71-0.69 (d, J = 5.6 Hz, d, J = 5.3 Hz, 3H); 13C NMR 
(100 MHz, CDCl3): δ 139.4, 136.0, 133.5, 133.4, 
130.1, 128.7, 128.3, 128.2, 126.8, 96.7, 75.3 (75.29), 
56.9, 55.4, 47.9 (47.7), 40.0, 30.0, 23.0, 20.5, 17.1 
(17.09); Exact mas: [M-H]+calcd. for [C30H42NO3SSi]+ 
524.2649, found 524.2655. 







(S,S,R)-10 and (S,S,S)-10 
Following the procedure for synthesis of compound 
10, using (±)-4 (5.0 g, 16.7 mmol), Li (1.4 g, 167 mmol), 
and (S)-9 (1.2 g, 5.6 mmol) gave sulfinamides (S,S,R) 
and (S,S,S)-10 (1.4 g, 50%). Rf = 0.34 (hexane / ethyl 
acetate1:1); 1H NMR (400 MHz, CDCl3): δ 7.7-7.2 (m, 
15H), 4.44-4.43 (m, 2H), 3.84-3.78 (m, 1H), 3.2 (s, 3H), 
3.1-2.8 (m, 4H), 1.73-1.65 (m, 1H), 1.2-1.0 (m, 1H), 1.0 
(s, 9H), 0.9-0.8 (m, 1H), 0.75-0.64 (m, 3H); 13C NMR 
(100MHz, CDCl3): δ 139.1, 135.9, 133.4, 133.2, 129.9, 
128.5, 128.2, 128.0, 126.6, 96.5, 75.1 (75.0), 56.7, 55.2, 
47.7 (47.5), 39.8, 29.8, 22.8 (22.6), 20.3, 16.9. 
 
Preparation of compound (R,S)-11 and (R,R)-11 
To a solution of two diastereomers (R,R,S)-10 and 
(R,R,R)-10 (1.0 g, 1.9 mmol) in a flask was added 
1.25M HCl (6.0 mL, 7.6 mmol) in methanol#1. The 
solution was stirred at rt for 5 h, concentrated  
in vacuo, dissolved in ethyl acetate (8 mL), added 
saturated NaHCO3 (3 ml) followed benzoyl chloride 
(0.26 mL, 2.28 mmol). The mixture was stirred at rt. 
for 3h, diluted with water (30 ml). The aqueous  
layer was extracted with ethyl acetate (3 × 10 mL). 
Combined organic layers were washed with water  
(3 × 10 mL), brine (2 × 10 mL), dried over with 
Na2SO4, and then concentrated in vacuo. Column 
chromatography gave (R,S)-11 (327 mg, 35%) and 
(R,R)-11 (227 mg, 25%). 
# Or using aqueous HCl in MeOH 
 
Preparation of Mixture of (S,R)-11 and (S,S)-11 
Following the procedure for synthesis of(R,S)-11 
and (R,R)-11, using the mixture of two diastereomers 
(S,S,S)-10 and (S,S,R)-10 (1.0 g, 1.9 mmol), 1.25M 
HCl (6.0 mL, 7.6 mmol). Column chromatography 
gave (S,R)-11 and (S,S)-11 mixture (637 g, 70% 
yield). Rf = 0.5 (hexane / ethyl acetate 1:1). 
 
Preparation of 3-(((R)-1-benzamido-2-phenylethyl) 
diphenylsilyl)-2(R)-methylpropanoic acid ((R,R)-
12) and 3-(((R)-1-benzamido-2-phenylethyl) 
diphenylsilyl)-2(S)-methylpropanoic acid ((R,S)-12) 
To a solution of (R,S)-11 and (R,R)-11 (0.5 g, 1.04 
mmol) in acetonitrile and water (2/1, 10 mL) at rt was 
added (2,2,6,6-tetramethyl-piperidin-1-yl)oxyl (TEMPO, 
32 mg, 0.2 mmol), and bis(acetoxy)iodobenzene 
(BAIB, 0.73 g, 2.2 mmol). The solution was stirred at 
rt for 2 h, quenched with 30% Na2S2O3 (20 mL). The 
aqueous layer was extracted with DCM (3 × 10 mL). 
The combined DCM layers were washed with water 
(3 × 10 mL), brine (2 × 5 mL), dried over with 
MgSO4, and then concentrated in vacuo. Column 
chromatography gave (R,S)-12 and (R,R)-12 (369 mg, 
72%); Rf = 0.31 (hexane / ethyl acetate 3:1). 
Following the procedure for synthesis of (R,S)-12 
and (R,R)-12, using the mixture of (S,R)-11 and (S,S)-
11 (1.0 g, 2.1 mmol), TEMPO (62 mg, 0.4 mmol), 
and BAIB (1.4 g, 4.4 mmol) gave a mixture of (S,R)-
12 and (S,S)-12 (750 mg, 72%yied); Rf = 0.29 (tail) 
(hexane / ethylacetate 3:1). 
 




To a 0°C solution of acid (R,S)-12 (0.5 g, 1.0 
mmol) and 13 (0.21 g, 1.0 mmol) in DMF (10 mL) 
was added 90% diethyl cyanophosphonate (0.23 mL, 
1.2 mmol) followed by triethylamine (0.46 mL, 3.3 
mmol). The reaction was stirred at 0°C for 3 h, and at 
rt overnight. The mixture was diluted with ethyl 
acetate (30 mL) and water (50 mL). The aqueous 
layer was extracted with ethyl acetate (3 × 10 mL). 
The combined organic layers were washed with 5% 
HCl (3 × 10 mL), saturated NaHCO3 (3 x 10 mL), 
water (3 × 10 mL), brine (10 mL), dried over with 
Na2SO4, and concentrated in vacuo. Column 
chromatography gave (R,S,S)-2 (0.53 g, 80%) as a 
colorless foam. Rf = 0.6 (hexane / ethyl acetate 3:1); 
1H NMR (400 MHz, CDCl3):δ 7.82-7.00 (m, 21H, 
included NH), 4.69-4.63 (m, 1H), 3.55 (dd, J = 8.4, 
3.6 Hz, 1H), 3.05-3.02 (m, 1H), 2.99 (dd, J = 14.0, 4.4 
Hz, 1H), 2.77 (dd, J = 14.0, 9.2 Hz, 1H), 2.42-2.37 
(m, 1H), 2.30-2.25 (m, 1H), 1.63-1.51 (m, 5H), 1.35 
(s, 9H), 1.23-1.19 (m, 1H), 1.12 (d, J = 6.8 Hz, 3H). 
 
Preparation of (S)-tert-Butyl-1-((R)-3-(((R)-  
1-benzamido-2-phenylethyl)diphenylsilyl)-2-
methylpropanoyl) pyrrolidine -2-carboxylate 
(R,R,S)-2 
Following the procedure for synthesis of(R,S,S)-2, 
using acid (R,R)-12 (0.5 g, 1.0 mmol), proline salt 13 
(0.21 g, 1.0 mmol) in DMF (10 mL), 90%  
diethyl cyanophosphonate (0.23 mL, 1.2 mmol), 
triethylamine (0.46 mL, 3.3 mmol) gave (R,R,S)-2 
(0.53 g, 80%) as a colorless foam. Rf = 0.31 (hexane / 
ethyl acetate 3:1); 1H NMR (400 MHz, CDCl3):  
δ 7.74-7.13 (m, 20H), 5.96 (d, J = 9.6 Hz, 1H),  
4.78-4.72 (m, 1H), 3.00 (dd, J = 14.2, 4.0 Hz, 1H), 
3.61 (dd, J = 7.9, 3.8 Hz, 1H), 3.13-3.06 (m, 8H), 




2.85-2.71 (m, 3H), 2.60-2.32 (m, 5H), 2.08-2.01 (m, 
1H), 1.81-1.38 (m, 12H), 1.35 (s, 9H), 1.34 (s, 9H), 
1.09 (d, J = 6.8 Hz, 3H), 1.04 (d, J = 6.8 Hz, 3H). 
Following the procedure for synthesis of(R,S,S)-2 
(p.182), using mixture of acid (S,R)-12 and (S,S)-12 
(0.8 g, 1.6 mmol), salt 13 (0.33 g, 1.6 mmol) in DMF 
(10 mL), diethyl cyanophosphonate (0.4 mL, 3.2 
mmol), triethylamine (0.67 mL, 4.8 mmol) gave 
(S,S,S)-2 (0.22 g, 41%) and (S,R,S)-2 (0.2 g, 37%) 
after flash column chromatography. 
 
Preparation of (S)-tert-Butyl 1-{(S)-3-[((S)- 
1-benzamido-2-phenylethyl)diphenylsilyl]-2-
methylpropanoyl} pyrrolidine -2-carboxylate 
(S,S,S)-2 
Rf = 0.45 (hexane / ethyl acetate 2:1) 
1H NMR (400 MHz, CDCl3):δ 7.59-7.12 (m, 20H), 
6.56 (d, J = 10.0 Hz, 1H), 4.75 (dt, J = 11.1, 4.0, Hz, 
1H), 4.20 (dd, J = 8.4, 4.0 Hz, 1H), 3.37-3.32 (m, 
1H), 3.19 (dd, J = 14.0, 4.0 Hz, 1H), 2.97- 2.91 (m, 
1H), 2.70-2.64 (m, 1H), 2.52 (dd, J = 14.0, 11.2 Hz, 
1H), 2.02-1.72 (m, 5H), 1.43 (s, 9H), 1.29-1.24  
(m, 1H), 1.20 (d, J = 6.5 Hz, 3H). 
 




Rf = 0.27 (hexane / ethyl acetate 2:1); 1H NMR  
(400 MHz, CDCl3):δ 7.74-7.13 (m, 40H), 6.00 (d,  
J = 10.0 Hz, 1H), 4.78-4.72 (m, 2H), 4.23 (dd, J =8.4, 
3.6 Hz, 1H), 3.61 (dd, J = 8.0, 3.8 Hz, 1H), 3.13-3.06 
(m, 8H), 2.85-2.71 (m, 3H), 2.60-2.32 (m, 5H), 2.08-
2.01 (m, 1H), 1.81-1.38 (m, 12H), 1.35 (s, 9H), 1.34 (s, 




carboxylic acid (R,S,S)-14 
To a 0°C solution of (R,S,S)-2 (0.2 g, 0.3 mmol) in 
DCM (10 mL) was added trifluoromethane sulfonic 
acid (3.8 mL, 18 mmol). The solution was stirred for 
1h at 0 °C, diluted with DCM (10.0 mL) followed by 
14.8 N NH4OH (1.0 mL) and stirred for 35min at  
0 °C, and then added 48% HF solution (0.6 mL) to 
give a pH of 2-3. Stirring was continued for 10 min. 
After addition of DCM (20 mL), the solution was 
washed with water (10 mL), saturated NaCl (10 mL), 
dried over Na2SO4, concentrated to give (R,S,S)-14 
(145 mg, 92%) as a light yellow foam. 1H NMR (400 
MHz, DMSO-d6):δ10.1 (br, 1H), 7.91-7.17 (m, 10H), 
4.0 (dd, J = 7.2, 4.1 Hz, 1H), 3.47-3.45 (m, 2H), 3.1 (dd, 
J = 14.0, 4.2 Hz, 1H), 3.0-2.98 (m, 1H), 2.9 (dd, J = 14.0, 
8.0 Hz, 1H), 2.8-2.7(m, 1H), 1.84 – 1.69 (m, 4H), 1.0 (d, 




pyrrolidine-2-carboxylic acid (R,R,S)-14 
Following the procedure for synthesis of(R,S,S)-14, 
using (R,R,S)-2 (0.2 g, 0.3 mmol) in DCM  
(10 mL), trifluoromethane sulfonic acid (1.8 mL,  
8.4 mmol), 14.8 N NH4OH (1.0 mL), and 48% HF 
solution (0.6 mL) gave (R,R,S)-14 (145 mg, 92%) as a 
light yellow foam. 1H NMR (400 MHz, CD3CN): 
δ 8.10 (brs, 1H), 7.80-7.21 (m, 10H), 4.42 (dd, J = 
8.0, 2.8 Hz, 1H), 3.47 (m, 2H), 3.18 (dd, J = 14.0, 3.4 
Hz, 1H), 3.12-3.08 (m, 1H), 2.85- 2.82 (m, 1H), 2.77 
(dd, J = 13.6, 10.0 Hz, 1H), 2.17-2.11 (m, 1H), 2.01-
1.96 (m, 1H), 1.88-1.68 (m, 2H), 1.30-1.15 (m, 1H), 




pyrrolidine-2-carboxylic acid (S,S,S)-14 
Following the procedure for synthesis of(R,S,S)-14 
(p.185), using (S,S,S)-2 (0.2 g, 0.3 mmol) in DCM  
(10 mL), trifluoromethane sulfonic acid (1.8 mL, 8.4 
mmol), 14.8 N NH4OH (1.0 mL), and 48% HF 
solution (0.6 mL) gave (S,S,S)-14 (145 mg, 92%) as a 
light yellow foam. 1H NMR (400 MHz, acetone_d6): 
δ 8.2 (br s, 1H), 7.99-7.20 (m, 10H), 4.15 (dd, J = 8.0, 
2.8 Hz, 1H), 3.56-3.47 (m, 2H), 3.24-3.15 (m, 2H), 
2.93-2.73 (m, 2H), 1.86-1.81 (m, 2H), 1.60-1.56 (m, 
2H), 1.22-1.18 (m, 1H), 1.13 (d, J = 6.8 Hz, 3H), 




pyrrolidine-2-carboxylic acid (S,R,S)-14 
Following the procedure for synthesis of(R,S,S)-14 
(p.185), using (S,R,S)-2 (0.2 g, 0.3 mmol) in DCM 
(10 mL), trifluoromethane sulfonic acid (1.8 mL, 8.4 
mmol), 14.8 N NH4OH (1.0 mL), and 48% HF 
solution (0.6 mL) gave (S,R,S)-14 (145 mg, 92%) as a 
light yellow solid. 1H NMR (400 MHz, acetone_d6): 
δ 8.27 (br s, 1H), 7.9-7.3 (m, 10H), 4.5 (dd, J = 8.0, 
2.9 Hz, 1H), 3.76 (m, 1H), 3.63 (m, 1H), 3.3 (dd,  
J =14.0, 3.6 Hz, 1H), 3.2-3.1 (m, 1H), 3.07-3.02  
(m, 1H), 2.96-2.85 (m, 1H), 2.2-2.17 (m, 1H), 2.1- 
2.06 (m, 1H), 2.04-1.97 (m, 1H), 1.88-1.79 (m, 1H), 
1.4-1.29 (m, 1H),1.28 (d, J = 6.4 Hz, 3H), 1.08- 0.92 
(m, 1H). 




Preparation of Sodium (S)-1-((S)-3-(((R)- 
1-benzamido-2-phenylethyl)dihydroxysilyl)-2-
methylpropanoyl) pyrrolidine-2-carboxylate (R,S,S)-1 
To a 0 °C solution of acid (R,S,S)-14 (9.0 mg,  
19.0 µmol) in 1:99 CD3CN/D2O (0.4 mL) was added 
a 0.2 M NaOH solution in D2O (0.3 mL, 57.0 µmol). 
The reaction was monitored by 19F NMR, and gave 
silanediol sodium salt (R,S,S)-1. 1H NMR (400 MHz, 
1% CD3CN in D2O): δ 7.47-7.10 (m, 10H), 4.02 (dd, 
J = 8.7, 4.4 Hz, 1H), 3.66 (dd, J = 13.0, 3.2Hz, 1H), 
3.43-3.29 (m, 2H), 3.07 (dd, J = 14.0, 3.2Hz, 1H), 
2.72-2.66 (m, 2H), 1.97-1.92 (m, 1H), 1.76-1.65 (m, 
2H), 1.60-1.54 (m, 1H), 1.08 (d, J = 6.5 Hz, 3H), 0.78 
(dd, J = 14.8, 3.6 Hz, 1H), 0.58 (dd, J = 15.0, 10.8 
Hz, 1H). 
 




1H NMR (400 MHz, 1% CD3CN in D2O): δ 7.50-
7.10 (m, 10H), 4.12 (dd, J = 8.8, 4.4 Hz, 1H), 3.58 
(dd, J = 13.0, 3.6 Hz, 1H), 3.51-3.31 (m, 2H), 3.01 
(dd, J =14.0, 3.2 Hz, 1H), 2.87-2.86 (m, 1H), 2.70  
(t, J = 13.0 Hz, 1H), 2.14-2.08 (m, 1H), 1.89-1.69 (m, 
3H), 1.03 (d, J = 6.0 Hz, 3H), 0.76 (dd, J = 15.2, 4.4 
Hz, 1H), 0.60 (dd, J = 15.0, 10.5 Hz, 1H). 
 




1H NMR (400 MHz, 1% CD3CN in D2O): δ 7.49-
7.11 (m, 10H), 4.08 (dd, J = 8.8, 4.4 Hz, 1H), 3.62 
(dd, J = 13.0, 3.6 Hz, 1H), 3.53-3.32 (m, 2H), 3.05 
(dd, J = 14.0, 3.6 Hz, 1H), 2.86-2.79 (m, 1H), 2.68  
(t, J = 13.0 Hz, 1H), 2.04-2.00 (m, 1H), 1.82-1.62  
(m, 3H), 1.06 (d, J = 6.5 Hz, 3H), 0.76 (dd, J = 15.1, 
4.4 Hz, 1H), 0.60 (dd, J = 15.0, 10.0 Hz, 1H). 
 




1H NMR (400 MHz, 1% CD3CN in D2O): δ 7.50-
7.10 (m, 10H), 4.28 (dd, J = 8.8, 4.4 Hz, 1H), 3.61 
(dd, J = 12.8, 3.0 Hz, 1H), 3.34- 3.28 (m, 2H), 2.97 
(dd, J =14.0, 3.0 Hz, 1H), 2.70-2.67 (m, 1H), 2.63  
(t, J = 7.6 Hz, 1H), 2.05-1.84 (m, 2H), 1.63-1.56  
(m, 2H), 0.94 (d, J = 6.5 Hz, 3H), 0.83 (dd, J = 15.2, 
4.0 Hz, 1H), 0.68 (dd, J = 15.2, 5.0 Hz, 1H). 
Conclusion 
In summary, four diastereomers of the ACE 
silanediol inhibitors 1 were synthesized via an 
addition of a silyllithium to an Ellman sulfinimine to 
control the first stereogenic center. Simple column 
chromatography could separate each pair of 
diastereomers 2. The synthesis is 8 linear steps from 
inexpensive starting material-dichlorodiphenylsilane 
(5) in over all yield 8%. 
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